Hodgkin lymphoma patients with bulky lymph nodes estimated by power Doppler ultrasound scanning

09-22-2006

Power Doppler ultrasound (US) scanning could be used to estimate bulky lymph nodes in Hodgkin lymphoma patients.

According to a study from Italy, "The accuracy of standard methods in estimating bulky lesions requires validation. We used clinical/computed tomography (CT) evaluation and power Doppler US to detect bulky disease in 137 consecutive Hodgkin's lymphoma patients, and analyzed the prognostic relevance of each method."

"Bulky disease was detected by clinical/CT evaluation in 47% of the patients and by power Doppler US in 20%. After treatment, at multivariate analysis power Doppler US-selected bulky disease was the parameter that best correlated with freedom from treatment failure (p<.001)," explained M. Picardi and colleagues, Federico II University Medical School.

The researchers concluded, "Power Doppler US, a readily available imaging technique, provides a better prognostic classification by detecting true bulky disease more accurately."

Picardi and colleagues published the results of their research in Haematologica - the Hematology Journal (Estimation of bulky lymph nodes by power Doppler ultrasound scanning in patients with Hodgkin's lymphoma: a prospective study. Haematologica, 2006;91(7):960-963).

For additional information, contact B. Rotoli, Federico II University Medical School, Department of Biochemistry and Medical Biotechnology, Naples, Italy.

The publisher of the Haematologica - the Hematology Journal can be contacted at: Ferrata Storti Foundation, Strada Nuova 134, 27100 Pavia, Italy.

Keywords: Naples, Italy, Bulky Disease, Diagnosis, Diagnostics, Hematology, Hodgkin's Lymphoma, Oncology, Power Doppler Ultrasound Scan, Prognosis, Prognostics.

This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2006, Clinical Oncology Week via NewsRx.com.



Related Diseases: Hodgkin Lymphoma
Related Glossary Terms: CAT or CT Scan (Computed Tomography Scan), Hodgkin Lymphoma
 
RECENT NEWS
 
Acute Lymphocytic Leukemia (ALL)
2008 SF Leukemia Cup Regatta - Sailing for Leukemia
CombiMatrix Announces That Permission Has Been Granted to Begin Clinical Trial for Leuchemix Drug
Improved Survival in Pediatric Leukemia Following Unrelated Bone Marrow but not Peripheral Blood Stem Cell Transplantation
Hana Biosciences' rALLy Clinical Trial of Marqibo Meets Response Criteria to Advance to Full Enrollment
Rituxan® Maintenance in Follicular Lymphoma Deemed Cost-effective
Acute Myeloid Leukemia (AML)
2008 SF Leukemia Cup Regatta - Sailing for Leukemia
CombiMatrix Announces That Permission Has Been Granted to Begin Clinical Trial for Leuchemix Drug
Improved Survival in Pediatric Leukemia Following Unrelated Bone Marrow but not Peripheral Blood Stem Cell Transplantation
New leukemia signal could point way to better treatment, Stanford researchers find
Cyclacel expands Phase 2 sapacitabine trial in elderly AML to include patients with MDS
Amyloidosis
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
STEM CELL TRANSPLANTATION PROCEDURE RESULTS IN LONG-TERM SURVIVAL FOR AMYLOIDOSIS PATIENTS
Neurochem receives approvable letter for eprodisate (KIACTA) for treatment of AA amyloidosis
Neurochem, Inc. (NRMX) Receives Approvable Letter for Eprodisate (KIACTA(TM)) for Treatment of AA Amyloidosis; FDA Asks for More Data
Aplastic Anemia
Blood Stem Cells Originate in the Placenta
Stem Cells from a Person's Own Umbilical Cord Effective Treatment For Life-Threatening Blood Disease, Study Data Show
Alexion's Soliris Granted Marketing Approval in Europe for Treatment of All Patients With PNH
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
Decision Fails Patients with Transfusion-Dependent Anemia
Chronic Lymphocytic Leukemia (CLL)
Phase III Study of Rituxan in Leukemia Meets its Goal
2008 SF Leukemia Cup Regatta - Sailing for Leukemia
CombiMatrix Announces That Permission Has Been Granted to Begin Clinical Trial for Leuchemix Drug
Improved Survival in Pediatric Leukemia Following Unrelated Bone Marrow but not Peripheral Blood Stem Cell Transplantation
Injection of Umbilical Cord Stem Cells into Bone Appears Promising for Leukemia
Chronic Myeloid Leukemia (CML)
2008 SF Leukemia Cup Regatta - Sailing for Leukemia
CombiMatrix Announces That Permission Has Been Granted to Begin Clinical Trial for Leuchemix Drug
Improved Survival in Pediatric Leukemia Following Unrelated Bone Marrow but not Peripheral Blood Stem Cell Transplantation
Promyelocytic Blast Crisis of Chronic Myeloid Leukemia during Imatinib Treatment
Injection of Umbilical Cord Stem Cells into Bone Appears Promising for Leukemia
Hodgkin Lymphoma
Hodgkin lymphoma -- new characteristics discovered
Queen's University Using Xceed Molecular's Ziplex in Follicular Lymphoma Study
Lymphoma 101: Everything you need to know
September Is National Leukemia and Lymphoma Awareness Month
Nerve cancer mutations found
Multiple Myeloma
Thalomid® in Induction Improves Progression-free Survival in Elderly with Myeloma
The IMF says journal editorial documents dramatic increase in survival since the 1980s
FDA Approves Vidaza Label Expansion
Bortezomib (Velcade) in Combo Scores For Initial Myeloma Treatment
B-MS boosts biologics pipeline with PDL BioPharma deal
Myelodysplastic Syndrome (MDS)
Cyclacel expands Phase 2 sapacitabine trial in elderly AML to include patients with MDS
FDA Approves Vidaza Label Expansion
Xanthus Presents Updated Xanafide Phase 2 Data Showing Durable Complete Remissions in Secondary AML
Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine (VNP40101M) in Combination with Cytarabine
ZIOPHARM Presents Positive Data From Phase II Study Of Darinaparsin In Advanced Hematological Malignancies At AACR 2008 Annual Meeting
Non-Hodgkin Lymphoma (NHL)
Queen's University Using Xceed Molecular's Ziplex in Follicular Lymphoma Study
Lymphoma 101: Everything you need to know
Dose Intensity Associated with Survival in Non-Hodgkin’s Lymphoma
September Is National Leukemia and Lymphoma Awareness Month
Dose Intensity Associated with Survival in Non-Hodgkin’s Lymphoma
Testicular Cancer
Single Dose of Carboplatin as Effective as Radiation Therapy for Testicular Cancer
Single Dose of Chemotherapy as Effective as Weeks of Radiation Therapy for Testicular Cancer
Drug avoids radiation for early testicular cancer
Polymorphism Reduces Benefit of Bleomycin in Testicular Cancer
Increased Life Expectancy Seen For Patients With Advanced Colorectal, Ovarian and Testicular Cancer